These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3415204)

  • 1. An accurate method for cytostatic dosimetry in isolation perfusion based on limb vascular volume determination.
    Lejeune FJ; Ghanem GE; Liénard D; Ewalenko P
    Antibiot Chemother (1971); 1988; 40():63-76. PubMed ID: 3415204
    [No Abstract]   [Full Text] [Related]  

  • 2. A simple and accurate new method for cytostatics dosimetry in isolation perfusion of the limbs based on exchangeable blood volume determination.
    Lejeune FJ; Ghanem GE
    Cancer Res; 1987 Jan; 47(2):639-43. PubMed ID: 3791248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions.
    Wieberdink J; Benckhuysen C; Braat RP; van Slooten EA; Olthuis GA
    Eur J Cancer Clin Oncol; 1982 Oct; 18(10):905-10. PubMed ID: 6891640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of melphalan in isolated limb perfusion.
    Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
    Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of dosimetric methods in isolated limb perfusion with melphalan for malignant melanoma of the lower extremity.
    Byrne DS; McKay AJ; Blackie R; MacKie RM
    Eur J Cancer; 1996 Nov; 32A(12):2082-7. PubMed ID: 9014749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion.
    Cheng TY; Grubbs E; Abdul-Wahab O; Leu SY; Hung CF; Petros W; Aloia T; Fedrau R; Pruitt S; Colvin M; Friedman H; Tyler D
    Am J Surg; 2003 Nov; 186(5):460-7. PubMed ID: 14599607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
    Hohenberger P; Bida B; Schlag PM
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():14-5. PubMed ID: 8946039
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated hyperthermic perfusion with mitoxantrone of melphalan in malignant melanoma of the limb.
    Huber R; Krüger I; Kuper K; Huber PM; Pichlmaier H
    Am J Surg; 1995 Oct; 170(4):345-52. PubMed ID: 7573726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic isolated limb perfusion in the management of extremity sarcoma.
    Hoekstra HJ; van Ginkel RJ
    Curr Opin Oncol; 2003 Jul; 15(4):300-3. PubMed ID: 12874508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
    Santillan AA; Zager JS
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1033-7. PubMed ID: 20078252
    [No Abstract]   [Full Text] [Related]  

  • 13. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.
    Thompson JF; Siebert GA; Anissimov YG; Smithers BM; Doubrovsky A; Anderson CD; Roberts MS
    Br J Cancer; 2001 Jul; 85(2):157-65. PubMed ID: 11461070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of soft tissue malignancies of the extremities by regional perfusion.
    Nachbur B; Vogt W; Goldhirsch A
    Antibiot Chemother (1971); 1988; 40():77-93. PubMed ID: 3046477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circuit and protocol for hypoxic hyperthermic isolated limb perfusion to treat malignant melanoma.
    Innet LM; Haripershad V; Van Den Berg J; Cooper L
    Perfusion; 2001 Jul; 16(4):325-30. PubMed ID: 11486853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ
    Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.
    Kroon BB
    Eur J Surg Oncol; 1988 Apr; 14(2):101-10. PubMed ID: 3360151
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan.
    Hohenberger P; Latz E; Kettelhack C; Rezaei AH; Schumann R; Schlag PM
    Ann Surg Oncol; 2003 Jun; 10(5):562-8. PubMed ID: 12794024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.